Establishment of a Tumor-bearing Mouse Model Stably Expressing Human Tumor Antigens Survivin and MUC1 VNTRs
Establishment of a Tumor-bearing Mouse Model Stably Expressing Human Tumor Antigens Survivin and MUC1 VNTRs作者机构:China-Japan Union Hospital of Jilin UniversityChangchun 130033P.R.China National Engineering Lab of AIDS VaccineCollege of Life ScienceJilin UniversityChangchun 130012P.R.China
出 版 物:《Chemical Research in Chinese Universities》 (高等学校化学研究(英文版))
年 卷 期:2012年第28卷第2期
页 面:259-263页
核心收录:
学科分类:0710[理学-生物学] 07[理学] 0905[农学-畜牧学] 08[工学] 09[农学] 071007[理学-遗传学] 0901[农学-作物学] 0836[工学-生物工程] 090102[农学-作物遗传育种]
基 金:Supported by the National Natural Science Foundation of China(No.30872396) the Scientific Research Foundation of Jilin Province,China(Nos.20080709,200905169) the Jilin University Basic Research Project,China(No.200903255)
主 题:Survivin MUC1 variable-number tandem repeat(MUC1 VNTR) Tumor antigen Tumor model Tumor vaccine
摘 要:The eukaryotic vectors VR1012 expressing survivin or 33 tandem repeats of human mucin 1(MUC1)(VNTRs),namely,VR1012-S and VR1012-VNTR(VNTR=variable number of tandem repeat),were constructed by cloning survivin and VNTR genes into VR1012,*** eukaryotic vector pEGFP expressing survivin and MUC1 VNTRs fusion gene pEGFP-MS was also *** melanoma cell line(B16) stably expressing survivin and MUC1 VNTRs(MS + B16) was established by Lipofectamine-mediated transfection of pEGFP-MS into B16 *** expression in MS + B16 cells was observed using a fluorescent microscope and survivin and MUC1 VNTRs(MS) expression was confirmed by means of Western blot analysis.A syngenic graft tumor model was generated by subcutaneous injection of MS + B16 cells into C57/BL6 mice and tumor size increased rapidly with time in a cell number dependent *** the third immunization,mice were challenged subcutaneously with 5×l0 5 MS + B16 *** with that of the negative control immunized with phosphate-buffered saline(PBS),a significant reduction of tumor growth was observed in groups immunized with survivin plasmid DNA and MUC1 VNTRs plasmid ***,the suppression of subcutaneous tumor was *** model is useful for the development of tumor vaccines targeting survivin and MUCI VNTRs.